Effective February 27, 2019, the board of directors of PhaseBio Pharmaceuticals, Inc. appointed Richard A. van den Broek to serve as a director of the Company. van den Broek will serve as a Class I director whose term will expire at the 2019 annual meeting of stockholders at which time he will stand for election by the Company’s stockholders. Richard A. van den Broek currently serves as managing partner of HSMR Advisors, LLC, a position he has held since February 2004.